Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

Clinical trial NCT00378911 · COMPLETED

Trial details

NCT number: NCT00378911
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Uterine Sarcoma Uterine Leiomyosarcoma

Start date: 2006-10-01
Primary completion: 2007-06-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.